ginsenoside-rg3 and Diabetic-Retinopathy

ginsenoside-rg3 has been researched along with Diabetic-Retinopathy* in 1 studies

Other Studies

1 other study(ies) available for ginsenoside-rg3 and Diabetic-Retinopathy

ArticleYear
Glucal-conjugated sterols as novel vascular leakage blocker: structure-activity relationship focusing on the C17-side chain.
    European journal of medicinal chemistry, 2014, Mar-21, Volume: 75

    A series of glucal-conjugated sterols as novel vascular leakage blocker were identified through design, synthesis and biologically evaluation. In addition, the structure-activity relationship (SAR) of the glucal-conjugated sterols focusing on the C17-side chain was also established. The sterol analogs linked with the rigid C17-side chain side chains exhibited potent cell survival activities. In particular, analog 21l, which possesses a cyclopentyl oxime moiety, was shown to have excellent pharmacological effects on retinal vascular leakage in a diabetic mouse model.

    Topics: Animals; Apoptosis; Calcium Gluconate; Cell Line; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelial Cells; Human Umbilical Vein Endothelial Cells; Mice; Mice, Inbred C57BL; Oximes; Permeability; Retina; Sterols; Structure-Activity Relationship

2014